A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CYH SEC filings page.
Community Health Systems, Inc. (CYH) reported $11.7B in revenue over the twelve months to Sep 30, 2026, down 7.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025's profit recovery came from sharply better operating performance, not revenue growth, while debt reduction remains central to the balance sheet.
Revenue fell1.2% while operating income rose174.5% , so the rebound was not volume-led. The 7.6-percentage-point margin expansion points to materially improved operating economics, whether through cost absorption, mix, or other operating changes.
Operating cash flow of
Liabilities were
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Community Health Systems, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Community Health Systems, Inc. scores 62/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Community Health Systems, Inc. scores 30/100 on it among other operating companies.
Community Health Systems, Inc.'s net debt of $10.1B, being $10.4B of long-term debt less $260.0M of cash, came to 5.29 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Community Health Systems, Inc. scores 13/100 among other operating companies measured the same way.
Community Health Systems, Inc. held $1.46 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.46. Liquidity ranks operating companies on that ratio, and Community Health Systems, Inc. scores 41/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Community Health Systems, Inc. scores 29/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Community Health Systems, Inc. scores 65/100 on it among other operating companies.
Community Health Systems, Inc. scores 1.04, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $3.6B against total assets of $13.2B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Community Health Systems, Inc. passes 8 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, Community Health Systems, Inc. generates $1.07 in operating cash flow ($543.0M OCF vs $509.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Community Health Systems, Inc. earns $1.71 in operating income for every $1 of interest expense ($1.5B vs $872.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Community Health Systems, Inc. generated $2.8B in revenue in Q3 2026. This represents a decrease of 10.7% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.
Community Health Systems, Inc.'s EBITDA was $252.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 28.2% from the same quarter a year earlier. Against the prior quarter it is down 49.3%.
Community Health Systems, Inc. reported a net loss of $86.0M in Q3 2026. This represents a decrease of 166.2% from the same quarter a year earlier. Against the prior quarter it is down 222.9%.
Community Health Systems, Inc. earned -$0.63 per diluted share (EPS) in Q3 2026. This represents a decrease of 165.6% from the same quarter a year earlier. Against the prior quarter it is down 223.5%.
Cash & Balance Sheet
Community Health Systems, Inc. generated $67.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 1575.0% from the same quarter a year earlier. Against the prior quarter it is up 458.3%.
Community Health Systems, Inc. held $155.0M in cash against $9.6B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Community Health Systems, Inc.'s operating margin was 5.3% in Q3 2026, reflecting core business profitability. This is down 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.5 percentage points.
Community Health Systems, Inc.'s net profit margin was -3.1% in Q3 2026, showing the share of revenue converted to profit. This is down 7.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.6 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
Community Health Systems, Inc. invested $87.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 33.8% from the same quarter a year earlier. Against the prior quarter it is up 14.5%.
Not reported for Q3 2026.
Not reported for Q3 2026.
CYH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B-10.7% | $2.8B-9.8% | $3.0B-6.1% | $3.1B-4.8% | $3.1B-0.1% | $3.1B-0.2% | $3.2B+0.6% | $3.3B+2.6% |
| Operating Income | $146.0M-39.9% | $389.0M-24.0% | $281.0M-1.1% | $449.0M+61.5% | $243.0Mn/m | $512.0M+115.1% | $284.0M+22.9% | $278.0M-15.2% |
| EBITDA | $252.0M-28.2% | $497.0M-19.4% | $395.0M+1.5% | $558.0M+37.1% | $351.0Mn/m | $617.0M+70.0% | $389.0M+12.4% | $407.0M-9.4% |
| Interest Expense | $201.0M-7.4% | $207.0M-3.7% | $214.0M-2.3% | $221.0M+0.9% | $217.0M0.0% | $215.0M-0.5% | $219.0M+3.8% | $219.0M+4.3% |
| Income Tax | -$3.0Mn/m | $76.0M-35.6% | $89.0M+111.9% | $61.0M-33.0% | -$173.0Mn/m | $118.0M+391.7% | $42.0M+50.0% | $91.0M-15.7% |
| Net Income | -$86.0M-166.2% | $70.0M-75.2% | -$58.0Mn/m | $110.0Mn/m | $130.0Mn/m | $282.0Mn/m | -$13.0Mn/m | -$71.0M-251.1% |
| EPS (Basic) | -$0.63-164.9% | $0.51-75.8% | -$0.43n/m | $0.82n/m | $0.97n/m | $2.11n/m | -$0.10n/m | -$0.52-244.4% |
| EPS (Diluted) | -$0.63-165.6% | $0.51-75.6% | -$0.43n/m | $0.80n/m | $0.96n/m | $2.09n/m | -$0.10n/m | -$0.52-244.4% |
| Diluted Shares (Avg) | 136M+0.3% | 137M+1.2% | 134M+1.2% | N/A | 135M+2.1% | 135M+1.9% | 133M+1.2% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses.
CYH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.1B-8.5% | $12.2B-10.7% | $13.2B-5.1% | $13.2B-6.0% | $13.2B-4.8% | $13.6B-5.3% | $13.9B-3.7% | $14.1B-2.8% |
| Current Assets | $3.0B-6.2% | $3.1B-15.8% | $3.8B+10.7% | $3.2B-2.0% | $3.2B+2.9% | $3.7B+14.4% | $3.4B+7.3% | $3.3B+2.9% |
| Cash & Equivalents | $155.0M+26.0% | $149.0M-67.3% | $712.0M+65.2% | $260.0M+602.7% | $123.0M+272.7% | $456.0M+1069.2% | $431.0M+797.9% | $37.0M-2.6% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Accounts Receivable | $2.1B-2.6% | $2.1B-5.2% | $2.1B-8.0% | $2.1B-9.1% | $2.2B+5.7% | $2.3B+3.0% | $2.3B+6.0% | $2.3B+2.5% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $3.2B-8.7% | $3.2B-10.4% | $3.1B-17.3% | $3.3B-12.5% | $3.5B-10.2% | $3.6B-9.3% | $3.8B-4.3% | $3.8B-4.3% |
| Total Liabilities | $13.0B-8.1% | $13.0B-11.7% | $14.1B-7.1% | $14.0B-8.7% | $14.2B-6.5% | $14.7B-3.6% | $15.2B-0.5% | $15.4B+0.6% |
| Current Liabilities | $2.0B-7.2% | $2.0B-12.2% | $2.6B+8.3% | $2.2B-5.8% | $2.2B+2.4% | $2.3B+5.7% | $2.4B+11.0% | $2.3B+9.5% |
| Non-Current Liabilities | $11.0B-8.2% | $11.0B-11.6% | $11.6B-9.9% | $11.8B-9.2% | $12.0B-7.9% | $12.4B-5.1% | $12.8B-2.4% | $13.0B-0.8% |
| Long-Term Debt | $9.6B-9.6% | $9.6B-11.9% | $10.1B-10.4% | $10.4B-9.2% | $10.6B-7.7% | $10.8B-5.8% | $11.3B-2.0% | $11.4B-0.3% |
| Total Equity | -$1.5Bn/m | -$1.4Bn/m | -$1.5Bn/m | -$1.4Bn/m | -$1.5Bn/m | -$1.6Bn/m | -$1.9Bn/m | -$1.9Bn/m |
| Retained Earnings | -$3.6Bn/m | -$3.6Bn/m | -$3.6Bn/m | -$3.6Bn/m | -$3.7Bn/m | -$3.8Bn/m | -$4.1Bn/m | -$4.1Bn/m |
Not reported in any period shown, so not listed: Inventory.
CYH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $154.0M+123.2% | $88.0M0.0% | -$297.0M-347.5% | $266.0M+23.1% | $69.0M+3.0% | $88.0M-12.9% | $120.0M+25.0% | $216.0M+140.0% |
| Depreciation & Amortization | $106.0M-1.9% | $108.0M+2.9% | $114.0M+8.6% | $109.0M-15.5% | $108.0M-7.7% | $105.0M-16.0% | $105.0M-8.7% | $129.0M+6.6% |
| Stock-Based Compensation | $3.0Mn/m | $2.0M-33.3% | $3.0M-25.0% | N/A | -$1.0M-125.0% | $3.0M+50.0% | $4.0M-33.3% | N/A |
| Capital Expenditures | $87.0M+33.8% | $76.0M-16.5% | $76.0M-10.6% | $94.0M-13.8% | $65.0M-7.1% | $91.0M+3.4% | $85.0M-8.6% | $109.0M-0.9% |
| Free Cash Flow | $67.0M+1575.0% | $12.0Mn/m | -$373.0M-1165.7% | $172.0M+60.7% | $4.0Mn/m | -$3.0M-123.1% | $35.0M+1066.7% | $107.0Mn/m |
| Investing Cash Flow | -$106.0Mn/m | -$23.0M-106.7% | $1.0B+130.4% | $142.0Mn/m | -$81.0M-208.0% | $342.0Mn/m | $444.0Mn/m | -$143.0M-179.4% |
| Financing Cash Flow | -$42.0Mn/m | -$628.0Mn/m | -$274.0Mn/m | -$271.0Mn/m | -$321.0Mn/m | -$405.0Mn/m | -$170.0M-1407.7% | -$69.0Mn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CYH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 5.3%-2.6pp | 13.8%-2.6pp | 9.5%+0.5pp | 14.5%+5.9pp | 7.9%+14.5pp | 16.3%+8.8pp | 9.0%+1.6pp | 8.5%-1.8pp |
| Net Margin | -3.1%-7.3pp | 2.5%-6.5pp | -2.0%-1.6pp | 3.5%+5.7pp | 4.2%+16.9pp | 9.0%+9.4pp | -0.4%+0.9pp | -2.2%-3.7pp |
| Return on Assets | -0.7%-1.7pp | 0.6%-1.5pp | -0.4%-0.4pp | 0.8%+1.3pp | 1.0%+3.8pp | 2.1%+2.2pp | -0.1%+0.2pp | -0.5%-0.8pp |
| Current Ratio | 1.480.0x | 1.53-0.1x | 1.470.0x | 1.46+0.1x | 1.470.0x | 1.59+0.1x | 1.440.0x | 1.41-0.1x |
| Asset Turnover | 0.230.0x | 0.230.0x | 0.230.0x | 0.240.0x | 0.230.0x | 0.230.0x | 0.230.0x | 0.230.0x |
| FCF Margin | 2.4%+2.3pp | 0.4%+0.5pp | -12.6%-13.7pp | 5.5%+2.3pp | 0.1%+0.2pp | -0.1%-0.5pp | 1.1%+1.0pp | 3.3%+3.9pp |
Not reported in any period shown, so not listed: Gross Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity.
Note: Shareholder equity is negative (-$1.4B), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Community Health Systems, Inc. CYH | FY2025 | $12.5B | $509.0M | 4.1% | $227.1M | 40/100 |
| Auna S.A. AUNA | FY2025 | $1.3B | $29.0M | 2.2% | $288.8M | 54/100 |
| Strata Critical Medical, Inc. SRTA | FY2025 | $197.1M | $41.3M | 21.0% | $407.3M | 43/100 |
| The Pennant Group, Inc. PNTG | FY2025 | $947.7M | $29.6M | 3.1% | $1.2B | 50/100 |
| Nutex Health Inc. NUTX | FY2025 | $875.3M | $70.8M | 8.1% | $1.1B | 78/100 |
| Sonida Senior Living, Inc. SNDA | FY2025 | $381.1M | -$70.8M | -18.6% | $1.5B | 33/100 |
Where Community Health Systems, Inc. Ranks
Frequently Asked Questions
Community Health Systems, Inc. (CYH) reported $12.5B in total revenue for fiscal year 2025. This represents a -1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Community Health Systems, Inc. (CYH) revenue declined by 1.2% year-over-year, from $12.6B to $12.5B in fiscal year 2025.
Yes, Community Health Systems, Inc. (CYH) reported a net income of $36.0M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $509.0M, with a net profit margin of 4.1%.
Community Health Systems, Inc. (CYH) had EBITDA of $1.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Community Health Systems, Inc. (CYH) had $260.0M in cash and equivalents against $10.4B in long-term debt.
Community Health Systems, Inc. (CYH) had an operating margin of 11.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Community Health Systems, Inc. (CYH) had a net profit margin of 4.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Community Health Systems, Inc. (CYH) generated $208.0M in free cash flow during fiscal year 2025. This represents a 73.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Community Health Systems, Inc. (CYH) generated $543.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Community Health Systems, Inc. (CYH) had $13.2B in total assets as of fiscal year 2025, including both current and long-term assets.
Community Health Systems, Inc. (CYH) invested $335.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Community Health Systems, Inc. (CYH) had a current ratio of 1.46 as of fiscal year 2025, which is considered adequate.
Community Health Systems, Inc. (CYH) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Community Health Systems, Inc. (CYH) trades at 6.3x earnings, its market capitalization divided by $36.0M net income, trailing 12 months to September 30, 2026. The market capitalization is $227.1M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Community Health Systems, Inc. (CYH) trades at 0.0x sales, its market capitalization divided by $11.7B revenue, trailing 12 months to September 30, 2026. The market capitalization is $227.1M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Community Health Systems, Inc. (CYH) has negative shareholder equity of -$1.4B as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Community Health Systems, Inc. (CYH) has an Altman Z-Score of 1.04, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Community Health Systems, Inc. (CYH) has a Piotroski F-Score of 8 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Community Health Systems, Inc. (CYH) has an earnings quality ratio of 1.07x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Community Health Systems, Inc. (CYH) has an interest coverage ratio of 1.71x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Community Health Systems, Inc. (CYH) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.